GO Term | Evidence Code | PMID |
---|---|---|
glycerol catabolic process | ||
canonical glycolysis | ||
glyceraldehyde-3-phosphate biosynthetic process | ||
glycolytic process | ||
methylglyoxal biosynthetic process |
GO Term | Evidence Code | PMID |
---|---|---|
protein homodimerization activity | ||
triose-phosphate isomerase activity | ||
ubiquitin protein ligase binding | ||
methylglyoxal synthase activity | ||
protein binding |
DO ID | Disease Name | Source |
---|---|---|
DOID:0014667 | disease of metabolism | |
DOID:0050486 | exanthem | |
DOID:0050635 | alternating hemiplegia of childhood | |
DOID:0050700 | cardiomyopathy | |
DOID:0050757 | deafness-dystonia-optic neuronopathy syndrome | |
DOID:0050865 | tongue squamous cell carcinoma | |
DOID:0050884 | triosephosphate isomerase deficiency | |
DOID:0060041 | autism spectrum disorder | |
DOID:0080199 | colorectal carcinoma | |
DOID:0080326 | familial hypertrophic cardiomyopathy |
HPO ID | HPO Term |
---|---|
HP:0001878 | Hemolytic anemia |
HP:0001895 | Normochromic anemia |
HP:0001897 | Normocytic anemia |
HP:0001972 | Macrocytic anemia |
HP:0002059 | Cerebral atrophy |
HP:0002093 | Respiratory insufficiency |
HP:0002098 | Respiratory distress |
HP:0002317 | Unsteady gait |
HP:0002747 | Respiratory insufficiency due to muscle weakness |
HP:0002808 | Kyphosis |
Disease ID | Disease Name |
---|---|
ORPHA:868 |
|
OMIM:615512 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
174844 | WB:WBGene00006601 | ||
43582 | FB:FBgn0086355 | ||
100183090 | CIOIN09076 | ||
560753 | ZFIN:ZDB-GENE-020416-4 | DANRE11063 | |
192309 | ZFIN:ZDB-GENE-020416-3 | ||
103043519 | ASTMX06789 | ||
100528108 | ICTPU13731 | ||
113570639 | ELEEL07180 | ||
105028247 | ESOLU59353 | ||
100194617 | SALSA123361 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024